Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Corneal Neovascularization”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Early research (Phase 1)Ended earlyNCT01868360
What this trial is testing

Using Aflibercept Injection to Treat Blood Vessel Growth Over the Cornea

Who this might be right for
Corneal Neovascularization
Balamurali Ambati 2
Testing effectiveness (Phase 2)Study completedNCT01072357
What this trial is testing

Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival

Who this might be right for
Corneal NeovascularizationCorneal Graft Failure
Reza Dana, MD 30
Testing effectiveness (Phase 2)UnknownNCT05011916
What this trial is testing

The Safety and Efficacy of KDR2-2 Suspension Eye Drops in the Treatment of Corneal Neovascularization

Who this might be right for
Corneal Neovascularization
Zhongshan Ophthalmic Center, Sun Yat-sen University 60
Early research (Phase 1)WithdrawnNCT02042027
What this trial is testing

Subconjunctival IVIg (Gamunex-C) Injection for Corneal Neovascularization and Inflammatory Conditions

Who this might be right for
Corneal NeovascularizationCorneal Graft FailureAnterior Segment Inflammation
University of Utah
Not applicableStudy completedNCT01695655
What this trial is testing

Neovascularization Patterns in Corneal Graft Rejection

Who this might be right for
Corneal Transplant
University of Michigan 44
Not applicableUnknownNCT06412718
What this trial is testing

Validation of Human Drugs Target of Repurposed Drugs and Novel Therapies

Who this might be right for
Rare DiseasesAniridiaNeurotrophic Keratopathy+5 more
IRCCS Ospedale San Raffaele 274
Early research (Phase 1)Study completedNCT00559936
What this trial is testing

Topical Avastin for Treatment of Corneal Neovascularization

Who this might be right for
Corneal Neovascularization
Massachusetts Eye and Ear Infirmary 24
Testing effectiveness (Phase 2)Ended earlyNCT00915590
What this trial is testing

Topical IL-1-Ra for Treatment of Corneal Neovascularization

Who this might be right for
Corneal Neovascularization
Reza Dana, MD 10
Testing effectiveness (Phase 2)Study completedNCT01257750
What this trial is testing

Treatment of Corneal Neovascularization With Topical Pazopanib

Who this might be right for
Corneal Neovascularization
Reza Dana, MD 20
Testing effectiveness (Phase 2)Study completedNCT02592330
What this trial is testing

Limbal Stem Cell Deficiency (LSCD) Treatment With Cultivated Stem Cell (CALEC) Graft

Who this might be right for
Limbal Stem Cell Deficiency
Massachusetts Eye and Ear Infirmary 23
Early research (Phase 1)UnknownNCT04620109
What this trial is testing

Clinical Evaluation of Safety and Tolerability of KDR2-2 Eye Drops in Healthy Volunteers With Pharmacokinetic Assessment

Who this might be right for
Corneal Neovascularization
Guangzhou HuiBoRui Biological Pharmaceutical Technology Co. Ltd 62
Early research (Phase 1)UnknownNCT04215393
What this trial is testing

An Exploratory Clinical Trial Evaluating the Tolerability and Efficacy of KH906 in Patients With Corneal Neovascularization

Who this might be right for
Corneal Neovascularization
Chengdu Kanghong Biotech Co., Ltd. 39
Not applicableWithdrawnNCT00515684
What this trial is testing

Corneal Thinning During Topical Bevacizumab Therapy

Who this might be right for
Corneal Neovascularization
Yonsei University
Testing effectiveness (Phase 2)Study completedNCT01996826
What this trial is testing

A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival

Who this might be right for
Corneal NeovascularizationCorneal Graft Failure
Reza Dana, MD 75
Not applicableStudy completedNCT00004430
What this trial is testing

Randomized Study of Photodynamic Therapy Using Dihematoporphyrin in Patients With Corneal Neovascularization

Who this might be right for
Corneal Neovascularization
Medical College of Hampton Roads 150
Testing effectiveness (Phase 2)Study completedNCT01843101
What this trial is testing

Investigation of Different Scanning Protocols for 3 Dimensional High-resolution Imaging of the Human Cornea With Optical Coherence Tomography (OCT) - A Pilot Study

Who this might be right for
Corneal NeovascularisationKeratoconus
Medical University of Vienna 13
Early research (Phase 1)Study completedNCT00769145
What this trial is testing

Ranibizumab for the Inhibition of Neovascularization in the Cornea Following Corneal Transplant Surgery

Who this might be right for
Corneal Neovascularization
University of Miami 5
Large-scale testing (Phase 3)Study completedNCT00555594
What this trial is testing

Prospective Study to Determine the Effect of Subconjunctival Bevacizumab (AVASTIN) in Corneal Neovascularization

Who this might be right for
Corneal Neovascularization
Asociación para Evitar la Ceguera en México 18
Not applicableStudy completedNCT00681603
What this trial is testing

Safety and Effectiveness of Subconjunctival Injection of Bevacizumab in the Treatment of Corneal Neovasculization

Who this might be right for
Lipid KeratopathyPenetrating KeratoplastyHerpetic Keratopathy+1 more
National Taiwan University Hospital 13
Not applicableUnknownNCT05659940
What this trial is testing

Correlation Between a Novel Subset of Neutrophil and Corneal Neovascularization.

Who this might be right for
Corneal NeovascularizationNeutrophils
Zhongshan Ophthalmic Center, Sun Yat-sen University 66
Next Page